Moneycontrol PRO
Open App
Live Now | Traders Conclave 2022 | India's Largest Retail Stock Investors & Traders Residential Conclave
you are here: HomeNewsTrendsHealth

COVID-19 booster dose | No certificate required for 60+ with co-morbidities

The ministry however said that such person can obtain the advice of their doctor before the precaution dose.

December 28, 2021 / 04:20 PM IST
Representative image

Representative image

The health ministry on December 28 said that all persons aged 60 years and above with co-morbidities will not be required to produce any certificate from the doctor to administration precaution dose.

"All persons aged 60 yrs & above with co-morbidities will not be required to produce/submit any certificate from the doctor, at the time of administration of precaution dose," Union Health Ministry was quoted by news agency ANI.

The ministry, however, said that such person can obtain the advice of their doctor before the precaution dose.

"...Such persons are expected to obtain the advice of their doctor before deciding to avail of precaution dose...," it added.

Also Read: Delhi government sounds yellow alert as Covid positivity crosses 0.5%

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

This comes after the home ministry on December 27 issued guidelines for COVID-19 vaccination of children aged 15-18 years and for the administration of booster dose to healthcare, frontline workers, and senior citizens with co-morbidity.

"For those Health Care Workers (HCWs) & Frontline Workers (FLWs) who have received two doses, another dose of COVID-19 vaccine would be provided from January 10," the ministry said in its guidelines.

"The prioritization & sequencing of this precaution dose would be based on the completion of 9 months from the date of administration of 2nd dose reads the guidelines," it said.

The Ministry also said that the Personnel to be deployed in Election Duty in poll-bound States will also be included in the category of frontline workers (FLWs).

Meanwhile, the country logged 653 cases of the Omicron variant of coronavirus across 21 states and UTs so far out of which 186 have recovered or migrated, the health ministry data updated on Tuesday showed.

Maharashtra recorded the maximum number of 167 cases followed by Delhi at 165, Kerala 57, Telangana 55, Gujarat 49 and Rajasthan 46.

With 6,358 people testing positive for coronavirus infections in a day, India’s total tally of COVID-19 cases rose to 3,47,99,691. The active cases have declined to 75,456, according to the data updated at 8 am.
Moneycontrol News
first published: Dec 28, 2021 04:18 pm
Sections
ISO 27001 - BSI Assurance Mark